DZS Software Solutions Releases Version 2.3 ClinPlus CTMS
DZS Software Solutions announced the release of ClinPlus CTMS version 2.3, a Clinical Trial Management System (CTMS) that includes 70 enhancements, most based on customer feedback.
Version 2.3 adds the ability to support read-only licenses and every ClinPlus CTMS client will receive five at no additional cost. Other areas of improvements include:
- Improved system navigation and administration
- Enhanced ad-hoc reporting features with additional metrics and standard reports
- Better manageability of global contact and institution databases
- More flexible control over role-based security and password recovery options
- Additional site reimbursement payment approval triggers (procedures, monitoring status, other)
- Improved site visit scheduling and an enhanced SVR authoring and review process
- Enhancements to eTMF features
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
